🔎 Trials Near Me

Hjem › Brystkreft › Ohio › Cleveland

Kliniske studier for Brystkreft i Cleveland, OH

35 studier for Brystkreft søker deltakere på steder i og rundt Cleveland (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

The Vanguard Study: Testing a New Way to Screen for Cancer

RekruttererFrivillige helsepersonell ønskes velkommen
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Alder 45 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06995898

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

Study of AVZO-021 in Patients With Advanced Solid Tumors

RekruttererFase 1/2
  • Avenzo Therapeutics Recruiting Site, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05867251

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06618287

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Rekrutterer
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

RekruttererFase 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Fairview Hospital, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07174336

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

RekruttererFase 1/2
  • UH Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07109726

Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer

Rekrutterer
  • Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland
Alder 18 til 65 · Kvinner · Oppdatert 15. sep. 2026 · NCT04362826

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

RekruttererFase 3
  • MetroHealth, Cleveland
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06492616

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RekruttererFase 1
  • University Hospital Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

RekruttererFase 1
  • Cleveland Clinic Foundation, Cleveland
Alder 18 til 55 · Kvinner · Oppdatert 9. sep. 2026 · NCT07310420

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

RekruttererFase 3
  • Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • Hillcrest Hospital, Mayfield Heights · 12 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06790693

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

RekruttererFase 3
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

RekruttererFase 3
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • South Pointe Hospital, Warrensville Heights · 9 mi unna
  • og 1 flere
Alder 18 til 60 · Kvinner · Oppdatert 2. sep. 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

RekruttererFase 1
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07029399

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

RekruttererFase 1
  • Cleveland Clinic Taussig Cancer Institute, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT06774963

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

RekruttererFase 2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
  • Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
Alder 19 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06129747

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

RekruttererFase 2
  • Case Western Reserve University, Cleveland
Alder 18 til 55 · Kvinner · Oppdatert 27. jul. 2026 · NCT06184750

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Rekrutterer
  • Case Western Reserve University/University Hospitals Cleveland, Cleveland
Alder 65 og eldre · Kvinner · Oppdatert 17. jul. 2026 · NCT05535192

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer

RekruttererFase 1
  • UHCMC Seidman Cancer Center, Cleveland
Alder 18 og eldre · Kvinner · Oppdatert 15. jul. 2026 · NCT05996107

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • UH Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

RekruttererFase 3
  • University Hospitals Seidman Cancer Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT05696626

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

RekruttererFase 2
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

RekruttererFase 3
  • Case Western Reserve University, Cleveland
  • MetroHealth Medical Center, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • og 3 flere
Alder 50 til 70 · Alle kjønn · Oppdatert 23. apr. 2026 · NCT04852887

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

RekruttererFase 1/2
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 22. apr. 2026 · NCT05455619

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

RekruttererObservasjonsstudie
  • University Hospitals Seidman Cancer Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 23. feb. 2026 · NCT05974150

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Cleveland Clinic, Cleveland
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

RekruttererObservasjonsstudie
  • Cleveland Clinic Main Campus, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT06401421

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi unna
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

The Cancer of the Pancreas Screening-5 CAPS5)Study

RekruttererFase 3
  • Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 9. okt. 2025 · NCT02000089

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

RekruttererFase 3
  • Case Western Reserve University, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • og 3 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 8. okt. 2025 · NCT03418961

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

RekruttererFase 1
  • Exelixis Clinical Site #7, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 5. sep. 2025 · NCT05932862

Brystkreft-studier i andre byer

Andre studier i Cleveland

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.